NTRA News and Press, Natera Inc. From 09/29/22

Natera Announces 2025 ESG Goals with Publication of 2021 Report PR Newswire AUSTIN, Texas , Sept. 29, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the publication of ...

Summary As the era of free money comes to an end, the gene testing industry is faced with the challenge of transforming itself into a commercially viable sector. Though it is still early days for the industry, major players have embarked on restructuring efforts to transform thems...

Natera Presents New Colorectal and Breast Cancer Data at ESMO 2022, Highlighting Signatera's Ability to Inform Treatment Decisions in the Adjuvant and Neoadjuvant Settings PR Newswire Data from the largest real-world MRD study to date in resectable colorectal cancer re...

Natera Earns Great Place to Work Certification™ for Second Consecutive Year PR Newswire AUSTIN, Texas , Aug. 25, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, is proud to be certified by Great ...

Natera Announces Enrollment Completion for RenaCARE Study PR Newswire RenaCARE Study to Evaluate the Clinical Utility of Renasight in the Diagnosis and Management of Chronic Kidney Disease AUSTIN, Texas , Aug. 11, 2022 /PRNewswire/ -- Natera, In...

Natera Announces Q-Sub Filing with FDA for its Panorama® NIPT PR Newswire AUSTIN, Texas , Aug. 10, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, announced earlier today at the Canaccord Genui...

The following slide deck was published by Natera, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Natera, Inc. 2022 Q2 - Results - Earnings Call Presentation

Natera press release ( NASDAQ: NTRA ): Q2 GAAP EPS of -$1.50 in-line. Revenue of $198.2M (+39.5% Y/Y) beats by $4.53M . Natera anticipates 2022 total revenue of $805 million to $825 million; 2022 gross margin to be approximately 46% to 48% of revenues; selling, gen...

Natera Reports Second Quarter 2022 Financial Results PR Newswire AUSTIN, Texas , Aug. 4, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ:  NTRA), a global leader in cell-free DNA testing, today reported financial results for the second quarter ended June...

Natera Announces Second Quarter 2022 Earnings Conference Call PR Newswire AUSTIN, Texas , Aug. 1, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its seco...